AdaptHealth former CFO proposes $155K share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
AdaptHealth Corp. (AHCO) is named as issuer in a proposed sale by former CFO Jason Allen Clemens of 19,855 common shares. The listed aggregate market value is $154,712.15, the approximate sale date is November 11, 2026, Morgan Stanley Smith Barney LLC is listed as broker, and Nasdaq is named as the securities exchange.
Jason Allen Clemens's reported sales during the prior three months were 60,978 shares on November 6, 2026, for gross proceeds of $447,510.44, and 169,779 shares on November 5, 2026, for gross proceeds of $1,260,743.41.
Key Figures
Key Terms
Aggregate Market Value financial
Restricted Stock Vesting Under a Registered Plan financial
Gross Proceeds financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.